Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Chief Financial Officer acquired 932 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 1,968 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 1,880 shares (grant or award)
  14. 4 Planned sale Chief Operating Officer sold 200 shares at $20.00 ($4,000)
  15. 4 Planned sale Chief Operating Officer sold 1,801 shares at an average $20.09 ($36,179)
  16. 4 Planned sale Chief Operating Officer sold 9,152 shares at an average $20.06 ($183,568)
  17. 4 Planned sale Chief Operating Officer sold 8,644 shares at an average $20.09 ($173,632)
  18. 4 Planned sale Chief Operating Officer sold 1,501 shares at $20.00 ($30,020)
  19. 4 Planned sale Chief Operating Officer sold 9,587 shares at $18.09 ($173,466)
  20. 4 Grant or award Director acquired 3,180,155 shares (grant or award)

Page 5 of 11 · 203 filings